Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
about
Negative regulation of ERα by a novel protein CAC1 through association with histone demethylase LSD1Essential role of KIBRA in co-activator function of dynein light chain 1 in mammalian cellsUpstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway.A Review of the Clinical Implications of Breast Cancer BiologyThe therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumorsDeregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumorsUnsupervised feature construction and knowledge extraction from genome-wide assays of breast cancer with denoising autoencodersProteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.KBERG: KnowledgeBase for Estrogen Responsive Genes.Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor alpha to estrogen-responsive elementsTumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.Why does binding of proteins to DNA or proteins to proteins not necessarily spell function?Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein.Is oestrogen an important player in melanoma progression?Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging.Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifenSLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the Estrogen Receptor β-KLF5 Pathway.Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.A human estrogen receptor (ER)alpha mutation with differential responsiveness to nonsteroidal ligands: novel approaches for studying mechanism of ER action.An immunohistochemical study on the expression of sex steroid receptors in canine mammary tumors.The role of estrogen receptor in melanoma.Activation of aromatase expression by retinoic acid receptor-related orphan receptor (ROR) alpha in breast cancer cells: identification of a novel ROR response element.Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12.Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells.Selective disruption of ER{alpha} DNA-binding activity alters uterine responsiveness to estradiol.High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome.Advances in novel drug delivery strategies for breast cancer therapy.Intrinsically disordered proteins and novel strategies for drug discovery.Profile of ospemifene in the breast.Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status.A water-soluble perylene dye functionalised with a 17β-estradiol: a new fluorescent tool for steroid hormones.Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function.Fulvestrant - a new treatment for postmenopausal women with hormone-sensitive advanced breast cancer.Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.Genetic variability of microRNA regulome in human.Pathway analysis using random forests classification and regression.
P2860
Q24304751-CCC8B315-41F1-42BB-8751-88C516777C45Q24336790-810EE1C6-FDEC-4D9E-8C1E-00E39613716FQ24534439-3DCB42C2-8741-4310-97F4-7C64F28E1B9DQ26744288-7F47BD1A-EDDF-4F93-A8F1-B80DF7FB81B7Q26829978-845F37E2-0AF0-4736-8038-D42F1A728B05Q28296627-1300B8D8-D778-45D7-BB5A-DE57C2ACD37BQ30616727-D64B275F-077C-4243-AE24-0CC34C16E1BCQ31039477-2C068662-4FA2-4B46-A508-27C4F9B390F1Q33262961-3643D544-B6A5-4834-A1DC-876AAD59591FQ33291249-BCE8B764-9611-4085-84B7-EAD7C63BA796Q33594026-4A7DC097-35F5-488F-9A4A-ED42F4119F3FQ33632616-71EC1DD5-91B4-4095-86B4-F15868AFFEDFQ33740613-73E015D9-0155-42BD-942E-7D1868FB4EDDQ33874365-D44B2647-6C32-4F1F-B069-2F15DA3FEA37Q33889528-41180BA7-D850-4524-A484-A75479B02105Q34589095-AC7F8819-7D9B-4534-8980-8E56C467CA11Q35971744-66A635F6-45D5-4CCA-8226-544BA58BA3C2Q35996187-676DEF2B-746A-4BBB-A5AF-774C2A79810EQ36154555-A11BC4A8-6FD5-4B4F-A091-AAFB258DF6F1Q36434014-B92FD96B-2FD2-43B8-9C2A-B90EBE824F31Q36589865-B5C7F87B-FE2B-4D48-BF71-324BDF8C3314Q36624258-2D2F0174-D3A2-42F9-983E-95E395FDFE51Q36756436-77AC3542-E728-43B4-9ED2-C5AAA7D9D1F6Q36857706-FB229CD6-87B3-4EE5-B73D-2FB612C31498Q37004756-C0696C06-B214-4880-BBFB-F3090568377CQ37285287-7D9726B9-6537-4DDC-8FF8-80ED78AC5F42Q37382513-CBF98490-1408-45A6-AF39-83429C1EBB50Q37426728-D6D939A2-6D31-49F0-8E3D-4B1A8A43567FQ37484600-FD819628-917F-4357-87B7-739B57762C7EQ37500390-64A3088E-041A-4264-941C-A7C68DB4267AQ37777142-943548E9-E8D5-4C31-83E5-3928CB5AF364Q38007557-FE016F42-FE0E-4CAD-A53F-8C0EF7B12A6BQ38129004-F9F3738F-F40A-428B-8D93-26910A03D107Q38452169-8DF41DC1-1437-40F7-BE1A-C0BEAECEB86FQ39520931-E731D27E-B0C2-416D-BE3C-7059D414F2EAQ40318351-0DAC39E4-68B6-426E-8BE2-ED0B9F2ED570Q40464404-6DF88D7A-F771-495D-B560-72E1EC193F19Q41516113-910017EB-0ECE-46E6-98CF-2D1AAD207F49Q42037865-031C2FDB-6B0D-4FC0-A9F9-7AC88ED0D618Q44827793-B70B5886-1499-42D7-ACDD-405B5D208E86
P2860
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
description
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Advances in estrogen receptor ...... targeted breast cancer therapy
@ast
Advances in estrogen receptor ...... targeted breast cancer therapy
@en
Advances in estrogen receptor ...... targeted breast cancer therapy
@nl
type
label
Advances in estrogen receptor ...... targeted breast cancer therapy
@ast
Advances in estrogen receptor ...... targeted breast cancer therapy
@en
Advances in estrogen receptor ...... targeted breast cancer therapy
@nl
prefLabel
Advances in estrogen receptor ...... targeted breast cancer therapy
@ast
Advances in estrogen receptor ...... targeted breast cancer therapy
@en
Advances in estrogen receptor ...... targeted breast cancer therapy
@nl
P2860
P921
P3181
P356
P1476
Advances in estrogen receptor ...... targeted breast cancer therapy
@en
P2093
Wenlin Shao
P2860
P2888
P3181
P356
10.1186/BCR742
P407
P50
P577
2003-11-07T00:00:00Z
2004-01-01T00:00:00Z
P5875
P6179
1038916225